Table 1.
Baseline characteristics of study patients with NTMLD diagnosis.
| Variable | GPs | PNs |
|---|---|---|
| N | 159 | 236 |
| Age | ||
| Mean (±SD) | 59,3 (±19.1) | 61,7 (±14.3) |
| <50 | 38 (24%) | 33 (14%) |
| 50–59 | 32 (20%) | 57 (24%) |
| 60–69 | 32 (20%) | 69 (29%) |
| 70–79 | 40 (25%) | 64 (27%) |
| ≥80 | 17 (11%) | 13 (6%) |
| Female | 81 (51%) | 138 (58%) |
| Male | 78 (49%) | 98 (42%) |
| Private health insurance coverage | 8 (5%) | 16 (7%) |
| Statutory health insurance coverage | 151 (95%) | 220 (93%) |
| Diagnosis documented within 12 months prior to the index date | ||
| COPD | 46 (29%) | 99 (42%) |
| Tuberculosis | 30 (19%) | 52 (22%) |
| Reflux Disease | 27 (17%) | 14 (6%) |
| Asthma | 14 (9%) | 33 (14%) |
| Coronary Heart Disease | 14 (9%) | 0 (0%) |
| Chronic bronchitis, emphysema | 11 (7%) | 35 (15%) |
| Bronchiectasis | 8 (5%) | 33 (14%) |
| Rheumatoid Arthritis | 8 (5%) | 0 (0%) |
| Lung Cancer | 3 (2%) | 9 (4%) |